Edwards Lifesciences Stock Forecast
NYSE: EWHealthcareMedical DevicesUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
EW analyst consensus
Consensus (29 analysts)
buy
Avg. price target
$101.96+18.86%
- Strong buy 5
- Buy 18
- Hold 6
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 29 Wall Street analysts covering Edwards Lifesciences (2026-10-08), 23 rate the stock a buy or strong buy, 6 rate it a hold and 0 rate it a sell or strong sell, for a consensus rating of "buy". The average 12-month price target is $101.96, with a high estimate of $110.00 and a low estimate of $84.00. The average target implies upside of 18.9% from the current price of $85.78.
The spread between the highest and lowest targets is 31.0%, a relatively narrow range. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for EW.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 5 | 17% |
| Buy | 18 | 62% |
| Hold | 6 | 21% |
| Sell | 0 | 0% |
| Strong sell | 0 | 0% |
Ratings as of 2026-10-08.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $84.00 | -2.08% |
| Average target | $101.96 | +18.86% |
| High target | $110.00 | +28.24% |